Hypertonic sodium chloride, a salt solution more concentrated than your body’s own fluids, is used to treat dangerously low sodium levels, reduce brain swelling, and improve airway clearance in lung conditions like cystic fibrosis. It works by pulling water out of swollen tissues through osmosis, making it a powerful tool in emergency and critical care settings. The concentrations used range from 3% to 23.4%, compared to the 0.9% “normal” saline you might receive during a routine IV.
How Hypertonicity Works in the Body
Your blood and body fluids normally contain about 0.9% sodium chloride. When a solution with a higher concentration enters your bloodstream, water naturally moves from areas of lower salt concentration to higher salt concentration. This is basic osmosis, and it’s the mechanism behind every clinical use of hypertonic saline.
In practical terms, this means hypertonic saline draws water out of cells and tissues into the bloodstream. That fluid shift accomplishes several things at once: it reduces swelling in tissues where excess fluid is dangerous (like the brain), it expands blood volume in patients who need it, and it restores the normal size and function of the cells lining blood vessels. That last effect, normalizing endothelial cell volume, plays an important role in stabilizing blood pressure during critical illness.
Reducing Brain Swelling After Injury
The most prominent use of hypertonic saline is managing elevated intracranial pressure, the dangerous buildup of pressure inside the skull that occurs after traumatic brain injuries, strokes, brain hemorrhages, and other neurological emergencies. When the brain swells, it has nowhere to expand inside the rigid skull, so even small reductions in fluid volume can prevent life-threatening compression of brain tissue.
Hypertonic saline draws excess water out of swollen brain cells and into the bloodstream, where it can be filtered by the kidneys. Neurocritical care guidelines now suggest hypertonic sodium solutions over mannitol (the traditional alternative) as the first-line treatment for elevated intracranial pressure in patients with traumatic brain injury and brain hemorrhage. For other conditions like ischemic stroke and hepatic encephalopathy, guidelines consider hypertonic saline and mannitol equally appropriate.
The most commonly studied concentration is 3%, typically given as a bolus rather than a continuous drip. Research on traumatic brain injury patients found that 3% hypertonic saline was more effective than mannitol at improving neurological scores after decompressive surgery. Higher concentrations, up to 23.4%, are reserved for refractory cases where standard doses aren’t controlling the pressure. These highly concentrated solutions are given in small volumes of 15 to 30 mL over 20 to 30 minutes. In one documented case, a patient received 16 doses of 23.4% hypertonic saline over five days to control pressure that wasn’t responding to other treatments.
Correcting Dangerously Low Sodium
Severe hyponatremia, where blood sodium drops well below normal levels, causes symptoms that range from headache and confusion to seizures, coma, and death. Hypertonic saline is the primary treatment for raising sodium levels when symptoms become moderate or severe.
The standard approach uses 150 mL boluses of 3% sodium chloride, each infused over 20 minutes. For moderate symptoms like headache, confusion, or nausea, a single bolus is typically enough, with the goal of raising sodium by at least 5 mEq/L over 24 hours. For severe symptoms like seizures, vomiting, or loss of consciousness, repeated boluses are given to achieve a 5 mEq/L increase within the first hour.
The critical safety limit in sodium correction is speed. Raising sodium too fast can cause osmotic demyelination syndrome, a condition where nerve fibers in the brain lose their protective coating, leading to potentially permanent neurological damage. Guidelines set the maximum correction at 10 mEq/L within any 24-hour period, with some guidelines using 8 mEq/L as the limit for subsequent days. This is why hypertonic saline for hyponatremia requires frequent blood draws to monitor sodium levels, sometimes every two to four hours.
Improving Lung Function in Cystic Fibrosis
Inhaled hypertonic saline serves a completely different purpose than intravenous formulations. In cystic fibrosis, a genetic defect causes the thin layer of liquid coating the airways to become depleted. Without adequate surface liquid, mucus becomes thick and sticky, clings to airway walls, and traps bacteria that cause chronic infections.
Nebulized hypertonic saline (typically 7%) draws water onto airway surfaces through the same osmotic principle, rehydrating the mucus layer so it can be coughed up more effectively. A landmark study published in the New England Journal of Medicine found that inhaling hypertonic saline four times daily produced a sustained increase in mucus clearance lasting eight hours or more per session. Patients also saw meaningful improvements in lung function, with forced expiratory volume (a measure of how much air you can blow out in one second) increasing by about 6.6% compared to baseline. Respiratory symptoms improved as well.
The researchers noted that the treatment’s benefits were somewhat limited because the nebulized saline couldn’t reach airways already blocked by thick mucus plugs. Still, the sustained hydration effect made it a useful addition to the daily treatment routine for people living with cystic fibrosis.
How It’s Given and What Concentrations Are Used
Hypertonic saline comes in concentrations ranging from 2% to 23.4%, and the route of administration depends on the concentration and the clinical situation. The 3% solution is the workhorse, used in the majority of both neurological and sodium-correction scenarios. It has traditionally been given through a central venous catheter (a line placed in a large vein near the heart) because of concerns that its high osmolarity could damage smaller veins. However, a systematic review of the evidence found that peripheral IV administration of 3% saline is generally safe, with low rates of vein irritation or infiltration. Even 23.4% saline, when studied in a small group of patients receiving it peripherally, showed minimal local complications.
For brain swelling, bolus dosing is preferred over continuous infusion. Boluses are typically repeated every four to six hours as needed. For sodium correction, the approach is more cautious, with careful monitoring between doses to avoid overcorrection.
Risks and Safety Concerns
The biggest risk of hypertonic saline is overcorrection of sodium levels. Osmotic demyelination syndrome, while rare, can cause difficulty speaking, swallowing problems, weakness, and in severe cases, a “locked-in” state where the patient is conscious but unable to move. This risk is highest in patients whose sodium has been low for more than 48 hours, giving the brain time to adapt to the low-sodium environment.
Fluid overload is another concern. Because hypertonic saline pulls water into the bloodstream, it expands blood volume rapidly. This is actually beneficial in patients with low blood pressure, but it can be dangerous for people with heart failure, liver cirrhosis, or kidney disease, all conditions where the body already struggles to handle excess fluid. The FDA label for 3% and 5% sodium chloride notes that no absolute contraindications exist, but it calls for particular caution in patients with conditions that promote sodium retention or fluid overload, including congestive heart failure, kidney disease, liver disease, and pre-eclampsia. Patients taking corticosteroids or lithium also need closer monitoring.
For inhaled hypertonic saline, the side effects are milder. Some people experience coughing or throat irritation during nebulization, and bronchospasm is possible, which is why a bronchodilator is often used beforehand. Serious adverse events from inhaled hypertonic saline are uncommon.